Nuveen Asset Management, LLC Durect Corp Transaction History

Nuveen Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.38 - $0.64 $317,901 - $535,413	-836,584 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.9 - $1.31 $68,052 - $99,054	-75,614 Reduced 8.29%	836,584 $757,000
Q3 2021 Nov 12, 2021	SELL	$1.21 - $1.61 $24,577 - $32,702	-20,312 Reduced 2.18%	912,198 $1.2 Million
Q2 2021 Aug 16, 2021	SELL	$1.6 - $2.02 $103,995 - $131,293	-64,997 Reduced 6.52%	932,510 $1.52 Million
Q1 2021 May 17, 2021	BUY	$1.86 - $2.87 $58,753 - $90,657	31,588 Added 3.27%	997,507 $1.98 Million
Q4 2020 May 17, 2021	SELL	$1.65 - $2.43 $57,187 - $84,221	-34,659 Reduced 3.46%	965,919 $2 Million
Q4 2020 Feb 16, 2021	BUY	$1.65 - $2.43 $100,009 - $147,287	60,612 Added 6.45%	1,000,578 $2.07 Million
Q3 2020 Nov 16, 2020	BUY	$1.6 - $2.35 $115,572 - $169,747	72,233 Added 8.32%	939,966 $1.61 Million
Q2 2020 Aug 14, 2020	BUY	$1.33 - $2.76 $1.15 Million - $2.39 Million	867,733 New	867,733 $2.01 Million

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $216M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.